A Step Toward Optimizing Regenerative Medicine Principle to Combat COVID-19
AbstractDrugs are currently not licensed in specific to pulverize COVID-19. On an emergency basis, vaccines were approved to prevent the further spread of COVID-19. This serves as a potential background for considering the optimization of biologics. In this context, evidence on convalescent plasma and stem cells has shown a beneficial role. Here, we have considered this as plausible therapy, and further hypothesize that their cocktails will synergistically boost the immunogenicity to relegate COVID-19. This warrants a large volume clinical trial on an emergent basis, because the sooner we establish a safe and effective cure, the better.
2019 ◽
Vol 14
(4)
◽
pp. 293-304
◽
2014 ◽
Vol 9
(6)
◽
pp. 451-451
Keyword(s):
2017 ◽
Vol 2
◽
pp. 173-180
◽